This inventor holds 1 USPTO granted patent. Top assignee: Creighton University. Active years: 2003.
Company Filing History:
Years Active: 2003
Title: Gizella Turi: Innovator in Antitumor Peptides
Introduction
Gizella Turi is a prominent inventor based in Budapest, Hungary. She has made significant contributions to the field of pharmaceuticals, particularly in the development of peptides with antitumor effects. Her innovative work has led to the creation of a patent that showcases her expertise and dedication to advancing medical science.
Latest Patents
Gizella Turi holds a patent for "GnRH analogues with antitumour effects and pharmaceutical compositions thereof." This invention provides peptides and pharmacologically active compounds, including gonadotropin-releasing hormone (GnRH) analogues, which demonstrate an antitumor effect. The patent outlines the formulas of these compounds and includes compositions that incorporate these peptides and compounds, highlighting their potential therapeutic applications.
Career Highlights
Gizella Turi is affiliated with Creighton University, where she continues her research and development in the pharmaceutical field. Her work has garnered attention for its innovative approach to cancer treatment, and she is recognized for her contributions to the scientific community.
Collaborations
Gizella has collaborated with notable colleagues, including Melinda Mora and Imre Mezom. These partnerships have further enriched her research and have contributed to the advancement of her innovative projects.
Conclusion
Gizella Turi is a trailblazer in the development of antitumor peptides, with a patent that underscores her commitment to improving cancer therapies. Her work at Creighton University and collaborations with esteemed colleagues reflect her significant impact on the field of pharmaceuticals.